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Abstract
Background: The discovery and development of anti-malarial compounds of plant origin and semisynthetic
derivatives thereof, such as quinine (QN) and chloroquine (CQ), has highlighted the importance of these
compounds in the treatment of malaria. Ursolic acid analogues bearing an acetyl group at C-3 have demonstrated
significant anti-malarial activity. With this in mind, two new series of betulinic acid (BA) and ursolic acid (UA)
derivatives with ester groups at C-3 were synthesized in an attempt to improve anti-malarial activity, reduce
cytotoxicity, and search for new targets. In vitro activity against CQ-sensitive Plasmodium falciparum 3D7 and an
evaluation of cytotoxicity in a mammalian cell line (HEK293T) are reported. Furthermore, two possible mechanisms
of action of anti-malarial compounds have been evaluated: effects on mitochondrial membrane potential (ΔΨm)
and inhibition of β-haematin formation.
Results: Among the 18 derivatives synthesized, those having shorter side chains were most effective against CQ-
sensitive P. falciparum 3D7, and were non-cytotoxic. These derivatives were three to five times more active than BA
and UA. A DiOC6(3) ΔΨm assay showed that mitochondria are not involved in their mechanism of action. Inhibition
of β-haematin formation by the active derivatives was weaker than with CQ. Compounds of the BA series were
generally more active against P. falciparum 3D7 than those of the UA series.
Conclusions: Three new anti-malarial prototypes were obtained from natural sources through an easy and
relatively inexpensive synthesis. They represent an alternative for new lead compounds for anti-malarial
chemotherapy.
Keywords: Plasmodium falciparum, Anti-malarial, Mitochondrial membrane potential, β-haematin, Betulinic acid,
Ursolic acid, Semisynthesis
Background
Malaria is among the most significant of infectious dis-
eases, influencing the health of humankind to this day
[1]. Plasmodium falciparum is a protozoan parasite and
the causative agent of the most virulent form of malaria
in humans. In endemic areas, malaria accounts for
nearly one million deaths, primarily among children
under the age of five [2].
Higher plants are commonly used as sources for the dis-
covery of new drug leads. Quinine (QN) and artemisinin
are examples of plant-derived products with anti-malarial
activity [3]. QN, one of the oldest and most important
anti-malarial agents, has long been extracted from the
bark of Cinchona (Rubiaceae) species [4]. Many other nat-
ural and semisynthetic anti-malarial compounds have
since been developed, most of which fall into three classes:
the quinolines, the artemisinin-based anti-malarials and
the antifolates [5]. Nevertheless, due to the emergence of
resistant Plasmodium strains, the therapeutic impact
of these compounds has declined, urging development of
new and effective anti-malarials [6]. The lack of low-cost
* Correspondence: simone.gnoatto@ufrgs.br
1Phytochemistry and Organic Synthesis Laboratory, School of Pharmacy,
Federal University of Rio Grande do Sul, Porto Alegre 90610-000, Brazil
Full list of author information is available at the end of the article
© 2013 da Silva et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Silva et al. Malaria Journal 2013, 12:89
http://www.malariajournal.com/content/12/1/89
and non-toxic drugs creates a very disturbing scenario for
malaria management, and greater efforts must be made
toward the discovery of new anti-malarial compounds [7].
The natural compound betulinic acid (3β-hydroxy-lup-20
(29)-en-28-oic acid, BA) has been shown to exhibit a variety
of biological activities, including inhibition of human im-
munodeficiency virus (HIV), antibacterial, anti-inflammatory,
anticancer and anti-helminthic effects [8,9]. The in vitro
anti-plasmodial activity (IC50) of BA against chloroquine
(CQ)-resistant (K1) and CQ-sensitive (T9-96) P. falcip-
arum strains was found to be 19.6 μg/mL and 25.9 μg/mL,
respectively. In a murine malaria model using Plasmodium
berghei NK65 strain, BA exhibited some toxicity when a
high dosage was employed (250 mg/kg/day), but no tox-
icity was observed at a dose of 125 mg/kg/day [10].
Another triterpene of pharmacological importance is
ursolic acid (3β-hydroxyurs-12-en-28-oic acid, UA), which
is known to have anti-inflammatory and antihyperlipidemic
properties as well as antitumour-promoting effects [11].
Moreover, UA has been shown to suppress parasitaemia
(96.9% at 60 mg/kg/day) in P. berghei-infected mice
and reduce in vitro proliferation of P. falciparum
strains 3D7, W2, and K1 [10,12]. The mechanism of
action of triterpenes as anti-malarials is not fully
understood. Gnoatto et al. [13] described seven new
ursolic acid analogues bearing an acetyl group at C-3
and a piperazine moiety at C-28 with significant anti-
malarial activity in the nanomolar range. The hydrophobic
interactions of the UA skeleton were also characterized
through molecular dynamic simulations, supporting the
binding of triterpene to haem as a mechanism of action for
these new UA derivatives. Therefore, the search for new
triterpene derivatives is a promising approach for de-
velopment of drugs with potential anti-malarial activity
(Figure 1).
In this context, the present study report the synthesis
and anti-malarial activity (against CQ-sensitive P. falcip-
arum 3D7) of two new series of BA and UA analogues
possessing various ester substituents at C-3, as well as
the in vitro cytotoxicity of the most active compounds in
HEK293T mammalian cells and their effect on mito-
chondrial membrane potential (ΔΨm) and inhibition of
β-haematin formation. These mechanisms of action are
likely involved in the anti-malarial activity of atovaquone
and CQ respectively [14,15].
Methods
Collection of plant materials and isolation of BA and UA
Platanus acerifolia bark was collected in Porto Alegre, RS,
Brazil. After botanical identification, a voucher specimen,
ICN 171329, was deposited in the Herbarium of the
Federal University of Rio Grande do Sul Department of
Botany. BA was isolated as described in the additional ma-
terial (Additional file 1) and its structure was confirmed
using spectroscopic data and comparison with the existing
literature [16]. UA was isolated from waste apple (Malus
domestica) peels obtained from a local juice factory. This
compound was identified using full spectroscopy data,
which consistent with those previously described [13].
Semisynthesis of the BA and UA series
All commercially available reagents were used without
further purification unless otherwise stated. Solvents
were distilled under a positive-pressure dry nitrogen at-
mosphere when necessary. Reactions requiring anhydrous
conditions were performed under a nitrogen atmosphere.
BA and UA derivatives were synthesized according to the
general procedure described in the literature [17]. Briefly,
the appropriate anhydride (1.1 mmol, 5 Eq) and DMAP
(0.22 mmol, 1 Eq) were added to BA or UA (0.22 mmol)
in pyridine or CH2Cl2 (2 mL) and refluxed for 24 hours
(for cyclic anhydrides) or processed without refluxing for
one hour (for acyclic anhydrides). Column chromatog-
raphy of the crude residue was performed to give the
expected pure compounds. Series BA and UA are illus-
trated in Figure 2.
Column chromatography was carried out using silica
gel 60 (Merck). Analytical thin layer chromatography
was performed on silica gel 60 F254 plates (Merck) and
spots visualized by spraying with anisaldehyde/sulphuric
Figure 1 Betulinic (BA) and ursolic (UA) acids.
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acid solution followed by heating at 100°C. Melting
points were determined using a Kofler bench. High-
resolution mass spectra (HR-EI-MS) were obtained on a
Micromass-Waters Q-TOF Ultima spectrometer. Infra-
red spectra were recorded on a PerkinElmer FTIR BX
spectrometer. 1H and 13C Nuclear Magnetic Resonance
(NMR) spectra were recorded on a Bruker AC 400 spec-
trometer operating at 300 and 75 MHz, respectively,
using tetramethylsilane as the internal standard and
chloroform-d. The chemical shifts (δ) were expressed in
parts per million (ppm).
Determination of in vitro anti-malarial activity
Plasmodium falciparum (3D7 strain) was cultured in
RPMI 1640 supplemented with 37.5 mM HEPES, 7 mM
D-glucose, 6 mM NaOH, 25 μg/mL gentamicin sulfate,
2 mM L-glutamine and 10% human serum and maintained
in human erythrocytes under a gas mixture of 5% O2, 5%
CO2, and 90% N2 [18]. Culture was synchronized by using
10% sorbitol [19]. Infected red blood cells (iRBC) with a
parasitaemia of 1–2% and a haematocrit of 2% were incu-
bated with compounds over a concentration range of 0.001
to 100 μM for 48 hours. CQ was included as positive con-
trol and the negative control was the solvent. Stock solu-
tions of CQ and test compounds, prepared in water and
dimethylsulfoxide (DMSO) respectively, were serially di-
luted with culture medium and added to synchronous
parasite cultures in 96-well plates, following the addition of
200 μL formaldehyde solution 2% per well, overnight. Para-
sitaemia was evaluated by Giemsa-stained smears and flow
cytometry. iRBCs were stained with YOYOW-1. The
concentration required to inhibit parasite growth was de-
termined by comparing the fluorescence of the treated and
untreated (control) cultures. The concentration causing
50% inhibition (IC50) was obtained from the drug concen-
tration response curve. The DMSO concentration never
exceeded 0.1% and did not inhibit parasite growth. The
definition of anti-malarial activity used herein was: IC50 ≤1
μM, potent activity; IC50 1-10 μM, good activity; IC50 10-
30 μM, moderate activity; IC50 ≥30 μM, inactive [20]. Re-
agents were purchased from Merck and Sigma-Aldrich.
In vitro cytotoxicity
Cytotoxicity was estimated using HEK293T (human em-
bryonic kidney) cells. This cell line was cultured in 75 sq
cm vented tissue culture flasks at 37°C in a humidified
atmosphere containing 5% CO2, in Dulbecco’s modified
essential medium (Gibco BRL) supplemented with 10%
(v/v) foetal bovine serum, 100 U/mL penicillin, and
100 μg/mL streptomycin. Cells (5.0 x 104/well) were
seeded into 48-well plates. Twenty-four hours after plat-
ing, cells were treated with decreasing concentrations
(100; 10; 1; 0.1; 0.01 and 0.001 μM) of compounds 1e, 1f
and 2e and evaluated after 24 and 48 hours. After incuba-
tion, cells were harvested with trypsin, gently centrifuged
and resuspended in phosphate buffer saline. The cells
were stained with dihydroethidium solution (10 mg/mL in
phosphate buffered saline), gently vortexed, and incubated
for 40 min at 37°C in the dark. Ten thousand gated events
were acquired for each sample (FACSCalibur, Becton &
Dickinson, and FlowJo software). The percentage of cell
viability calculated as intrinsic cytotoxicity is represented
Figure 2 Semisynthetic derivatives of series BA and UA. NS: Not synthesized.
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by the concentration leading to 50% of cell death (IC50)
on flow cytometry.
Determination of changes in mitochondrial membrane
potential (ΔΨm)
Changes in mitochondrial membrane potential were
assessed as per Srivastava et al. [14]. Accumulation of the
lipophilic cationic fluorescent probe 3,30-dihexyloxacarb
ocyanine iodide (DiOC6(3)) in mitochondria was assessed
in the presence of the active compounds 1e, 1f and 2e and
in their absence, in comparison with cells treated with the
mitochondrial respiratory chain uncoupler carbonyl cyan-
ide m-chlorophenyl hydrazone (CCCP). In this manner,
iRBC in RPMI 1640 medium containing 10% human
serum and 10% parasitaemia were incubated with a 2 nM
final concentration of DiOC6(3) for 30 min at 37°C. Vari-
ous concentrations of the compounds were then added to
the culture and incubated for an additional 30 min at 37°C.
At the end of the incubation period, samples were
centrifuged for 5 min at 3,700 rpm and the supernatant
discarded. Samples were then resuspended in phosphate
buffer saline and 105 events analyzed by flow cytometry.
Inhibition of β-haematin formation
Inhibition of β-haematin formation was determined as de-
scribed by Baelmens et al. [21]. CQ was used as the posi-
tive control. Briefly, 100 μL of a fresh 6.5 mM solution of
haemin in 0.2 M NaOH was mixed with 200 μL of 3 M
sodium acetate, 25 μL of 17.4 M acetic acid and 25 μL of
the tested compound or the solvent as negative control
(DMSO for 1e, 1f and 2e or water for CQ). The final con-
centration of compounds in wells ranged from 0.5 to 20
mM. After 24 hours of incubation while gently shaking at
37°C, samples were centrifuged for 15 min at 3,300 g, the
supernatant discarded and the pellet washed with 200 μL
DMSO. This latter step was repeated once more and the
pellet was finally washed with water. The pellet was then
dissolved in 200 μL of 0.1 M NaOH. After a further 1:8 di-
lution, absorption at 405 nm was measured using a
FlexStation plate reader. Experiments were carried out at
least in triplicate. Results are expressed as percentage of
inhibition of β-haematin formation in comparison to the
negative control result, as calculated with the equation
% Inhibition ¼ 100  1 OD drugð Þ= OD solventð Þð Þ
Statistical analysis
All results are expressed as mean ± standard error or
mean ± standard deviation of at least three individual
experiments. Student’s t test was chosen for between-
group comparisons, whereas repeated measures ANOVA
was used for comparisons amongst more than two groups.
Statistical significance was defined as p < 0.05. Analyses
were carried out in GraphPad Prism version 4.00 for Win-
dows (GraphPad Software, San Diego, CA USA).
Results
Description of natural triterpenes and their synthetic
derivatives
The structures of the isolated compounds are shown in
Figure 1, and their synthetic derivatives are shown in Figure 2.
The triterpene BA was isolated from P. acerifolia bark,
and UA from M. domestica peel; both sources were
highly advantageous due to their low cost and good
yields (2% for BA and 2.8% for UA; expressed in %
weight/weight of dried bark or raw material). After
semisynthesis of the eighteen compounds in series BA
and UA, their structural elucidation could be deduced
from IR, 1H, 13C NMR, HR-EI-MS and elemental ana-
lysis data (Additional file 2).
Plasmodium falciparum susceptibility
Table 1 presents the IC50 for the isolated and synthe-
sized compounds against CQ-sensitive P. falciparum
3D7 (IC50CQ = 29 nM). The IC50 for BA and UA were
18 and 36 μM respectively, which is consistent with pre-
viously published data [12,22]. Compounds 1e, 1f, and
2e showed good activity and BA, 1b, and 1h showed
moderate activity, whereas the other compounds, includ-
ing UA, were considered inactive.
Cytotoxicity of active compounds on HEK293T
mammalian cells
The IC50 of compounds 1e, 1f and 2e for HEK293T was
> 100 μM; therefore, none was cytotoxic in the tested
conditions.
Determination of changes in mitochondrial membrane
potential (ΔΨm)
Figure 3A presents the representative fluorescence histo-
gram for iRBC displacement in incubation with CCCP at
a concentration of 5 μM, indicating a differential probe
location and ideal experimental conditions. Histograms
obtained in control conditions (Figure 3B) and in the
presence of the active compounds 1e, 1f and 2e
(Figure 3C, 3D and 3E, respectively) showed a normal
mitochondrial membrane potential for the concentra-
tions tested, in the 0.25 nM–25 μM range. These results
suggest that the mechanism of anti-malarial action of
these compounds in P. falciparum iRBC is distinct from
that of atovaquone. Results were calculated from fluores-
cence intensity by flow cytometer setting.
Inhibition of β-haematin formation
Inhibition percentages for the most active derivatives are
reported in Table 2. CQ was significantly more efficient at
inhibiting β-haematin formation than all tested compounds.
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No statistically significant differences were found between
1e and 2e (derived from BA and UA respectively). This sug-
gests that the tested derivatives exert their anti-malarial ef-
fects via a mechanism of action distinct from that of CQ in
the haemin detoxification pathway.
Discussion
In this study, semisynthetic compounds were obtained,
derived from natural sources, with potential utility as anti-
malarial agents, using a simple and inexpensive strategy.
The triterpenes BA and UA exhibited moderate anti-
malarial activity in vitro [12,22]. Both compounds were
obtained from natural sources with good yields. This
work reported for the first time the semisynthesis of 18
BA and UA derivatives with ester substituents at C-3,
designed to improve anti-malarial activity, reduce cyto-
toxicity and search for new targets. These derivatives
were obtained using a single-step, inexpensive synthesis
adequate for industrial-scale processing. The anti-malarial
activities of the synthesized compounds were in the range
of 5 and >100 μM against CQ-sensitive P. falciparum
Table 1 Anti-malarial activity of isolated and synthesized
compounds against CQ-sensitive Plasmodium falciparum
3D7
Series BA Series UA
Compound IC50
a (μM) Compound IC50 (μM)
BA 18 ± 0.17 UA 36 ± 0.25
1a > 100 2a > 100
1b 29 ± 0.26 2b 71 ± 0.30
1c 44 ± 0.14 2c 72 ± 0.16
1d 70 ± 0.19 2d ND
1e 5 ± 0.14 2e 7 ± 0.15
1f 8 ± 0.16 2f > 100
1g 66 ± 0.25 2g 58 ± 0.13
1h 22 ± 0.17 2h 58 ± 0.32
1i > 100 2i > 100
1j ND 2j > 100
a: results expressed as mean ± standard error.
ND Not Determined;
BA Betulinic Acid.
UA Ursolic Acid.
Figure 3 Effect of derivatives on ΔΨm. Representative histograms showing the effect of higher concentration (25 μM) of derivatives 1e (3C), 1f
(3D) and 2e (3E) on ΔΨm by FACS analysis. Negative control (3B) for the fluorescence intensity of parasites in the presence of 2 nM DiOC6(3)
without any added inhibitors and with protonophore CCCP (5 μM) (3A).
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3D7, with three compounds exhibiting good activity
(1e, 1f and 2e). These three derivatives possessed a
four-carbon side-chain and had anti-malarial activity
three to five times greater than that of BA and UA.
Some reports have reported a change in activity af-
ter modification on the triterpene carbon 3. The
3-O-acetyl ester of ursolic acid exhibited enhanced ac-
tivity against CQ-resistant P. falciparum FcB1 (IC50 =
24.93 μM) as compared with UA (IC50 = 52.93 μM)
[13]. Interestingly, the 3-O-acetyl ester of oleanolic acid, an
isomer of UA, was also active against a multidrug-resistant
P. falciparum K1 strain [23]. In another study, the 3-O
-acetyl ester of lupeol containing a functional ester group at
C-3 was more active than its precursor against CQ-
resistant P. falciparum FCR-3 [24]. In view of these find-
ings, modifications at the C-3 position of BA and UA were
designed to evaluate the influence of side-chain length and
presence of polar or lipophilic groups (such as carboxylic
acids, aromatic rings or halogens) on their ability to impair
parasite growth. In these series, acylated derivatives with
shorter side-chains (1e, 1f and 2e) had improved anti-
malarial activity (IC50 = 5, 8 and 7 μM, respectively). It was
also obtained information on the presence of a second car-
boxylic acid group, as in derivatives 1d (IC50 = 70 μM), 1g
(IC50 = 66 μM) and 2g (IC50 = 58 μM); and the presence of
a halogen, such as chlorine and fluorine, as in derivatives
1h (IC50 = 22 μM), 1i (IC50 >100 μM), 2h (IC50 = 58 μM)
and 2i (IC50 >100 μM). These functional groups did not po-
tentiate anti-malarial action.
Comparison of derivatives with the same substituents
derived from series BA and series UA demonstrated that
BA derivatives are generally more active against P. falcip-
arum 3D7 strain than UA derivatives. The most active de-
rivatives synthesized, 1e, 1f and 2e, did not show any
cytotoxicity against HEK293T cells at the tested concen-
tration of 100 μM. This excellent result justifies potential
in vivo experiments with these compounds in future.
Follow-up studies with non-cytotoxic compounds are im-
portant, as adverse effects such as hypoglycaemia,
cardiotoxicity, and gastrointestinal discomfort have been
described with the anti-malarials: QN, halofantrine, and
CQ/proguanil [22].
The molecular mechanism of action of triterpenes
such as BA and UA is still poorly understood. Previous
research has suggested that the mechanism of action of
UA and its derivatives could be similar to that of CQ, i.e.
inhibition of β-haematin formation [13,25]. It was chose
to assess this mechanism of action and another mechan-
ism that has been suggested for an important anti-
malarial agent, atovaquone: an inhibitory effect on ΔΨm.
The ΔΨm consists of chemical and electrical compo-
nents generated by electron transport chain enzymes,
and its determination is widely used to characterize cel-
lular metabolism, viability and apoptosis [26]. The ΔΨm
assay was performed for the more active derivatives, 1e,
1f and 2e, by accumulation of the lipophilic cationic
fluorescent probe DiOC6(3). When DiOC6(3) is incu-
bated with iRBC, it diffuses into cells and concentrates
several orders of magnitude into negative-inside mito-
chondria. Probe accumulation into parasite mitochon-
dria is dependent on the presence of a membrane
potential, collapse of which will result in diffusion of the
probe out of the mitochondria, resulting in signal dissi-
pation. The tested derivatives did not exhibit histogram
displacement, as observed after incubation with CCCP,
indicating dissipation of the membrane potential and
abolition of probe accumulation. This experiment
showed that, unlike CCCP, the tested compounds were
not able to collapse ΔΨm (Figure 3).
Derivatives 1e, 1f and 2e were also evaluated for inhib-
ition of β-haematin formation, and displayed less inhibi-
tory activity than that of CQ. This assay is based on the
ability of Plasmodium to use haemoglobin as a source of
amino acids, resulting in the formation of potentially toxic
ferriprotoporphyrin IX. CQ and other anti-malarial drugs
act by inhibiting ferriprotoporphyrin IX detoxification
through haem polymerization. The action of these anti-
malarial drugs on β-haematin formation takes place dur-
ing the intra-erythrocytic phase of the parasite, within the
food vacuole. The parasite converts haem into the malarial
pigment haemozoin [15]. Derivatives 1e and 2e derivatives
exhibited similar inhibition percentages (25% and 26% re-
spectively), whereas 1f displayed less inhibitory activity
(14%) than the other tested derivatives. Thus, it was ob-
served that modification of carbon 3 plays an important
role in the inhibition of β-haematin formation.
Conclusion
In this study, 18 new derivatives of betulinic acid (series
BA) and ursolic acid (series UA) were synthesized with the
purpose of investigating the importance of substituents at
carbon 3 for anti-malarial activity against P. falciparum
3D7. Derivatives 1e, 1f and 2e exhibited good anti-malarial
activity in the micromolar range. Derivatives of series BA
were generally more active against P. falciparum 3D7 than
compounds derived from series UA, with a three- to five-
Table 2 Inhibition of β-haematin formation
Compound Concentration Inhibitionb IC50
c CQ
(mM) (%) (mM) indexa
Chloroquine 0.5 – 20 83 ± 1.07 3 ± 0.16 -
1e 0.5 – 19 25 ± 2.62 > 19 > 6.33
1f 0.5 – 20 14 ± 0.43 > 20 > 6.66
2e 0.5 – 19 26 ± 3.57 > 19 > 6.33
a calculated as compound IC50/CQ IC50.
b results are expressed as mean ± standard deviation at the highest
tested concentration.
c results are expressed as mean ± standard error.
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fold difference in activity in relation to their respective
aglycones. Furthermore, 1e, 1f and 2e did not exhibit any
cytotoxicity against a HEK293T cell line at 100 μM. Re-
garding mechanism of action, these triterpene derivatives
was weaker inhibit β-haematin formation than CQ and did
not act on ΔΨm. Further assays are required to elucidate
the pathways whereby these anti-malarial compounds exert
their effects. This study can contribute to the design and
development of potent anti-malarial compounds derived
from natural sources.
Additional files
Additional file 1: Extraction of BA and UA. Description: The data
provided represent the extraction of betulinic and ursolic acids.
Additional file 2: Identification of synthesized derivatives.
Description: The data provided represent the identification of the
synthesized derivatives.
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